You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antipsychotics Agents

Showing 1 - 25 of 5,774
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-acting Antipsychotics for Mental Ill-Health in Pregnancy

Not yet recruiting
  • Schizophrenia
  • +7 more
    • Makurdi, Benue State, Nigeria
    • +5 more
    Mar 9, 2023

    Schizophrenia; Psychosis, Metabolic Syndrome, Flupentixol Trial in Taichung (Flupentixol, Multi-acting receptor-targeted

    Completed
    • Schizophrenia; Psychosis
    • +7 more
    • Flupentixol
    • Multi-acting receptor-targeted antipsychotics (MARTAs)
    • Taichung, Taiwan
      Taichung Veterans General Hospital
    May 20, 2021

    Periodontitis in Schizophrenic Patients

    Completed
    • Schizophrenia Spectrum and Other Psychotic Disorders
    • Periodontal Diseases
    • antipsychotic drugs inducing hyperprolactinemia
    • Giza, Egypt
      Rania Hassan Shalby
    Sep 10, 2023

    Schizophrenia, Schizoaffective Disorder Trial in Toronto (Clozapine)

    Recruiting
    • Schizophrenia
    • Schizoaffective Disorder
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health
    Mar 11, 2022

    Maternal And Infant Antipsychotic Study

    Not yet recruiting
    • Antipsychotics
    • Pregnancy
    • (no location specified)
    Sep 16, 2023

    Schizophrenia and Related Disorders, Early Treatment-Resistance Trial in Worldwide (Clozapine, Second-line Antipsychotics

    Not yet recruiting
    • Schizophrenia and Related Disorders
    • Early Treatment-Resistance
    • Clozapine
    • Second-line Antipsychotics (treatment as usual)
    • Innsbruck, Austria
    • +12 more
    Jul 27, 2023

    Delirium Trial in Birmingham (Guanfacine, Placebo)

    Recruiting
    • Delirium
    • Birmingham, Alabama
      University of Alabama at Birmingham Hospital
    Nov 17, 2021

    Schizophrenia Relapse Trial (reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone,

    Completed
    Has Results
    • Schizophrenia Relapse
    • reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone, levomepromazine, perphenazine
    • (no location specified)
    Aug 11, 2021

    Metabolic Side-effects of Anti-psychotic Medications -Nested

    Active, not recruiting
    • Psychotic Disorders
    • Ramat Gan, Israel
      Sheba Medical Center, Psychiatry Department
    May 23, 2023

    Schizophrenia Trial in Taichung (NMDAE plus AIFA, NMDAE plus Placebo Cap)

    Recruiting
    • Schizophrenia
    • NMDAE plus AIFA
    • NMDAE plus Placebo Cap
    • Taichung, Taiwan
      Department of Psychiatry, China Medical University Hospital
    Jul 19, 2022

    Brexpiprazole in Schizophrenia and in Depressive Disorders

    Recruiting
    • Psychosis
    • Depression
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Jul 18, 2023

    Schizophrenia Trial in Denver (Ondansetron followed by , Placebo followed by Ondansetron)

    Completed
    Has Results
    • Schizophrenia
    • Ondansetron followed by placebo
    • Placebo followed by Ondansetron
    • Denver, Colorado
      Denver VAMC
    Jul 20, 2021

    Schizophrenia and Related Disorders, MDD, Bipolar Depression Trial (Clozapine, Esketamine Nasal Product, Escitalopram)

    Not yet recruiting
    • Schizophrenia and Related Disorders
    • +2 more
    • (no location specified)
    Jan 12, 2023

    Psychotic Disorders, Gastroesophageal Reflux Trial in Vancouver (Pantoprazole)

    Withdrawn
    • Psychotic Disorders
    • Gastroesophageal Reflux
    • Vancouver, British Columbia, Canada
      UBC Hospital - Detwiller Pavilion
    Oct 1, 2021

    Death, Sudden, Cardiac, Arrythmia, Antipsychotics and Neuroleptics Toxicity Trial in Denmark (Antipsychotic)

    Recruiting
    • Death, Sudden, Cardiac
    • +2 more
    • Aabenraa, Denmark
    • +17 more
    Feb 17, 2021

    Treatment-resistant Schizophrenia Trial in Columbus (Clozapine, Antipsychotics,Other (non-Clozapine))

    Not yet recruiting
    • Treatment-resistant Schizophrenia
    • Columbus, Ohio
      Ohio State University Harding Hospital
    Feb 22, 2023

    MDD Trial in Gwangju (stepwise pharamacotherapy, antidepressant monotherapy group)

    Recruiting
    • Major Depressive Disorder
    • stepwise pharamacotherapy
    • antidepressant monotherapy group
    • Gwangju, Korea, Republic of
      Chonnam National University Hospital
    Sep 19, 2023

    Hyperactive Delirium Trial in Alexandria (Quatiapine, Haloperidol)

    Recruiting
    • Hyperactive Delirium
    • Alexandria, Egypt
      Faculty of Medicine, Alexandria University Hospitals
    Jan 17, 2023

    Schizophrenia Spectrum Disorders Trial in Toronto (Semaglutide, Placebo)

    Recruiting
    • Schizophrenia Spectrum Disorders
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health
    Jun 27, 2022

    Stable Schizophrenia Trial in London (TAK-041, Placebo, Second Generation Antipsychotics (SGA))

    Completed
    Has Results
    • Stable Schizophrenia
    • London, United Kingdom
      Kings College London
    Mar 17, 2021

    Critical Illness, Delirium, Cognitive Impairment Trial in Nashville (Guanfacine, Placebo)

    Recruiting
    • Critical Illness
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jan 9, 2023

    Infectious Disease Trial (Start Antibiotics / Continue Antibiotics for treatment of bacteriuria, No Antibiotics for treatment of

    Not yet recruiting
    • Infectious Disease
    • Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
    • No Antibiotics for treatment of bacteriuria
    • (no location specified)
    Aug 21, 2023

    Legal Offenders With Schizophrenia,Prospective Observational

    Not yet recruiting
    • Schizophrenia
    • Zürich, Switzerland
      Psychiatrische Universitätsklinik Zürich
    Jul 1, 2023

    Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics Trial (Empagliflozin,

    Not yet recruiting
    • Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
    • (no location specified)
    Jan 22, 2023

    Schizophrenia Trial (asenapine, olanzapine)

    Completed
    • Schizophrenia
    • (no location specified)
    Feb 7, 2022